Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

104.41
Delayed Data
As of May 18
 -1.71 / -1.61%
Today’s Change
29.46
Today|||52-Week Range
108.00
+77.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues47.7M160.9M88.3M102.8M
 
 
 
 
 
Depreciation And Amortization352.0K639.0K1.7M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses28.4M36.1M55.8M76.1M
 
 
 
 
 
Research And Development18.7M23.2M40.5M57.5M
 
 
 
 
 
Total Operating Expenses28.8M36.7M57.4M78.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.0M124.1M30.8M24.6M
 
 
 
 
 
Extraordinary Credit--347.0K29.0K0.00
 
 
 
Extraordinary Charge-166.0K0.000.00-159.0K
 
 
 
Interest Expense On Debt18.0K8.0K45.0K40.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income19.3M125.5M32.6M26.9M
 
 
 
 
 
Income Taxes-15.2M-46.5M-10.9M-9.2M
 
 
 
 
 
Net Income34.4M79.0M21.7M17.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.4M18.7M18.9M19.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.2M19.3M19.2M19.4M
 
 
 
 
 
 
Earnings Per ShareEPS$1.80$4.09$1.13$0.91
 
 
 
 
 
EPS Diluted$1.80$4.09$1.13$0.91